Jon Napitupulu

Calidi Biotherapeutics announced preclinical success with its systemic RTNova platform, demonstrating effective delivery of gene therapy payloads to targeted...

Tonix Pharmaceuticals has received a grant from the Medical CBRN Defense Consortium (MCDC) to further develop TNX-801, a single-dose...

Blueberries Medical Corp. is raising approximately C$1.05 million (US$740,000) through a non-brokered private placement of 96,064,935 common shares at...

Artax Biopharma presented preclinical data on Nck modulators for atopic dermatitis at the 2025 American Academy of Dermatology Annual...

PDS Biotechnology Corporation has launched VERSATILE-003, a Phase 3 clinical trial for its immunotherapy drug, Versamune® HPV. The trial...

AskBio, a Bayer subsidiary, announced the advancement of its Phase 1/Phase 2 LION-CS101 clinical trial for AB-1003, a gene...

MindRank, an AI-driven drug discovery company, has received FDA Investigational New Drug (IND) application clearance for MRANK-106. MRANK-106 is...

Plus Therapeutics announced positive Phase 1 clinical trial results for Rhenium (¹⁸⁶Re) Obisbemeda in treating recurrent glioblastoma (GBM), published...

TG Therapeutics announced upcoming presentations of Briumvi (ublituximab-xiiy) data for relapsing multiple sclerosis (RMS) at the American Academy of...

I-Mab, a global biotech company, announced the completion of enrollment, ahead of schedule, in the first dose expansion cohort...